Burrill & CompanyBurrill & Company Contact: Roger Wyse
Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with over $500 million under management.
Burrill’s technical and venture investing competence spans the entire spectrum of life sciences. Within the clean technology sector we have invested in Cobalt Biofuels, Gebo, HCL Cleantech (Biofuels). Burrill principally invests in the United States and Europe, but has strategic interests globally. The average investment made by Burrill is $5-15 million over the life of any one company. We primarily invest at the first outside round and follow-on stages, and selectively engage in buyouts.